AIDS is a global pandemic with over 20 million HIV-infected individuals worldwide. A major focus within our laboratory has been defining the unique epidemiologic, clinical, virologic and immunologic features of HIV-1 and HIV-2 infections in developing countries and in the U.S. In Pune, India, we established a prospective cohort of over 3,000 high-risk individuals attending STD clinics, of whom 21% were seropositive for HIV-1. The HIV incidence was 10.2% with rates as high as 28% for commercial sex workers. Recurrent genital ulcers and non-ulcerative STDs were independently associated with a 7 and 3- fold increased risk of HIV seroconversion, respectively. Genetic analysis of viral strains demonstrated clade C2 and C3. A community-based STD mass treatment campaign among 5,000 individuals in Uganda resulted in a 60% reduction in the prevalence and incidence of bacterial STDs. In a multi-center study on perinatal transmission in the U.S., we determined that elevated RNA viral levels at birth were suggestive of in utero infection and that a high plasma RNA viral level in the first two months of life was associated with a rapid progression to AIDS or death. In addition, co- infection of the mother with HIV and hepatitis C virus (HCV) resulted in a 3-fold increase in perinatal transmission of HCV and a 2-fold increase in perinatal transmission of HIV. Short-course intermittent chemotherapy for tuberculosis in 427 patients in Haiti resulted in a 94% efficacy rate in HIV seropositive patients and 97.2% rate in HIV seronegative patients. In studies of HIV-1 and HTLV-1 co-infection in Brazil, we documented a higher incidence of myelopathy and peripheral neuropathy among dually infected individuals. In addition, T and B cell responses to pneumococcal and tetanus immunizations were markedly diminished among dually infected individuals compared to these infected with HIV-1 alone. Median serum HIV RNA levels were similar in both co-infected and singly infected patients, suggesting that the advanced neurologic abnormalities in co-infected patients were unrelated to HIV viral level.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI000361-14
Application #
2566759
Study Section
Special Emphasis Panel (LIR)
Project Start
Project End
Budget Start
Budget End
Support Year
14
Fiscal Year
1996
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Meya, David; Spacek, Lisa A; Tibenderana, Hilda et al. (2009) Development and evaluation of a clinical algorithm to monitor patients on antiretrovirals in resource-limited settings using adherence, clinical and CD4 cell count criteria. J Int AIDS Soc 12:3
Johnson, Kristine E; Quinn, Thomas C (2008) Update on male circumcision: prevention success and challenges ahead. Curr Infect Dis Rep 10:243-51
Blake, Diane R; Maldeis, Nancy; Barnes, Mathilda R et al. (2008) Cost-effectiveness of screening strategies for Chlamydia trachomatis using cervical swabs, urine, and self-obtained vaginal swabs in a sexually transmitted disease clinic setting. Sex Transm Dis 35:649-55
Chang, Larry William; Kagaayi, Joseph; Nakigozi, Gertrude et al. (2008) Telecommunications and health Care: an HIV/AIDS warmline for communication and consultation in Rakai, Uganda. J Int Assoc Physicians AIDS Care (Chic) 7:130-2
Blake, Diane R; Quinn, Thomas C; Gaydos, Charlotte A (2008) Should asymptomatic men be included in chlamydia screening programs? Cost-effectiveness of chlamydia screening among male and female entrants to a national job training program. Sex Transm Dis 35:91-101
NIMH Collaborative HIV/STD Prevention Trial Group (2007) The community popular opinion leader HIV prevention programme: conceptual basis and intervention procedures. AIDS 21 Suppl 2:S59-68
NIMH Collaborative HIV/STD Prevention Trial Group (2007) Ethical issues in the NIMH Collaborative HIV/STD Prevention Trial. AIDS 21 Suppl 2:S69-80
NIMH Collaborative HIV/STD Prevention Trial (2007) Role of the data safety and monitoring board in an international trial. AIDS 21 Suppl 2:S99-102
NIMH Collaborative HIV/STD Prevention Trial Group (2007) Challenges and processes of selecting outcome measures for the NIMH Collaborative HIV/STD Prevention Trial. AIDS 21 Suppl 2:S29-36
Gray, Ronald H; Li, Xianbin; Kigozi, Godfrey et al. (2007) The impact of male circumcision on HIV incidence and cost per infection prevented: a stochastic simulation model from Rakai, Uganda. AIDS 21:845-50

Showing the most recent 10 out of 123 publications